So the acting CEO believes strongly in vitiligo approval. I have slight optimism on the timing because clinuvel has finally learned to put rather conservative timelines out so at least they have a chance to meet or even beat them.
The spontaneous post trial tanning effect is interesting and points towards lasting and maybe curative effects. extra patients recruited, first effects quickly visible, placebo replaced by actual implant after trial, patients in the usa,EU and Africa, hands and feet hiatus is beggin for a topical. Second phase 3 in the works,
The absence of our CEO was indicated to be 3 months and that means he should be back next week or so to start his final contractual year.
Lets hope we get a statement soon. Its far too quiet lately. Hopefully we don't become a household name for the wrong reasons.
CUV Price at posting:
$10.30 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)